Zuranolone for the Treatment of Adults With Major Depressive Disorder: A Randomized, Placebo‐Controlled Phase 3 Trial

Allopregnanolone Mediates Affective Switching Through Modulation of Oscillatory States in the Basolateral Amygdala

(2021) Pantelis Antonoudiou et al.   BIOLOGICAL PSYCHIATRY

Effect of Zuranolone vs Placebo in Postpartum Depression

(2021) Kristina M. Deligiannidis et al.   JAMA Psychiatry

Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications

(2020) Fiammetta Cosci et al.   PSYCHOTHERAPY AND PSYCHOSOMATICS

Prevalence of Depression Symptoms in US Adults Before and During the COVID-19 Pandemic

(2020) Catherine K. Ettman et al.   JAMA Network Open

Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABAA receptor positive allosteric modulator

(2020) Alison L. Althaus et al.   NEUROPHARMACOLOGY

Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments

(2019) Ronald S. Duman et al.   NEURON

Reduced default mode network functional connectivity in patients with recurrent major depressive disorder

(2019) Chao-Gan Yan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Trial of SAGE-217 in Patients with Major Depressive Disorder

(2019) Handan Gunduz-Bruce et al.   NEW ENGLAND JOURNAL OF MEDICINE

Abuse Potential of Lasmiditan: A Phase 1 Randomized, Placebo‐ and Alprazolam‐Controlled Crossover Study

(2019) Darren Wilbraham et al.   JOURNAL OF CLINICAL PHARMACOLOGY

The State of US Health, 1990-2016

(2018) et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials

(2018) Samantha Meltzer-Brody et al.   LANCET

Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

(2018) Spencer L James et al.   LANCET

Neuroactive Steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano-1H-pyrazol-1′-yl)-19-nor-5β-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (γ-Aminobutyric Acid)A Receptor

(2017) Gabriel Martinez Botella et al.   JOURNAL OF MEDICINAL CHEMISTRY

Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial

(2017) Stephen Kanes et al.   LANCET

Endogenous and synthetic neuroactive steroids evoke sustained increases in the efficacy of GABAergic inhibition via a protein kinase C-dependent mechanism

(2017) Amit Modgil et al.   NEUROPHARMACOLOGY

Has the rising placebo response impacted antidepressant clinical trial outcome? Data from the US Food and Drug Administration 1987-2013

(2017) Arif Khan et al.   World Psychiatry

Simultaneous Antidepressant and Benzodiazepine New Use and Subsequent Long-term Benzodiazepine Use in Adults With Depression, United States, 2001-2014

(2017) Greta A. Bushnell et al.   JAMA Psychiatry

ANXIETY IN MAJOR DEPRESSION AND CEREBROSPINAL FLUID FREE GAMMA-AMINOBUTYRIC ACID

(2014) J. John Mann et al.   DEPRESSION AND ANXIETY

Neurosteroids promote phosphorylation and membrane insertion of extrasynaptic GABAA receptors

(2014) A. M. Abramian et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The impact of tonic GABAA receptor-mediated inhibition on neuronal excitability varies across brain region and cell type

(2014) Vallent Lee et al.   Frontiers in Neural Circuits

Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials

(2012) Craig H. Mallinckrod† et al.   DRUG INFORMATION JOURNAL

Benzodiazepine treatment induces subtype-specific changes in GABAA receptor trafficking and decreases synaptic inhibition

(2012) T. C. Jacob et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The GABAergic deficit hypothesis of major depressive disorder

(2010) B Luscher et al.   MOLECULAR PSYCHIATRY

The Descriptive Epidemiology of Commonly Occurring Mental Disorders in the United States

(2008) Ronald C. Kessler et al.   Annual Review of Public Health

Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration

(2008) Irving Kirsch et al.   PLOS MEDICINE